findmyKOL
Clinical trialNCT00368355CompletedPhase 2Interventional

T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

SponsorBaylor College of MedicineEnrollment46Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelogenous LeukemiaFamilial Hemophagocytic Lymphohistiocytosis (FLH)Hemophagocytic Lymphohistiocytosis (HLH)Myelodysplastic Syndrome+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Houston Methodist Hospital

    Houston, Texas, United States

  • Texas Children'S Hosptial

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2000
Primary completion
30 Nov 2015
Completion
30 Nov 2016
Last update posted
21 Jan 2020
Registered enrollment
46
Registry id
NCT00368355

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.